|
Originally published In Press as doi:10.1074/jbc.M004070200 on July 24, 2000
J. Biol. Chem., Vol. 275, Issue 40, 31514-31519, October 6, 2000
Expression of Rattus norvegicus mtDNA in
Mus musculus Cells Results in Multiple Respiratory Chain
Defects*
Matthew
McKenzie and
Ian
Trounce§
From the Mutation Research Centre and the University of Melbourne,
Department of Medicine, St. Vincent's Hospital, 41 Victoria
Parade, Fitzroy 3065 Melbourne, Australia
Received for publication, May 12, 2000, and in revised form, July 19, 2000
 |
ABSTRACT |
The production of in vitro and
in vivo models of mitochondrial DNA (mtDNA) defects is
currently limited by a lack of characterized mouse cell mtDNA mutants
that may be expected to model human mitochondrial diseases. Here we
describe the creation of transmitochondrial mouse (Mus
musculus) cells repopulated with mtDNA from different murid
species (xenomitochondrial cybrids). The closely related Mus
spretus mtDNA is readily maintained when introduced into M. musculus mtDNA-less ( 0) cells, and the resulting
cybrids have normal oxidative phosphorylation (OXPHOS). When the more
distantly related Rattus norvegicus mtDNA is transferred to
the mouse nuclear background the mtDNA is replicated, transcribed, and
translated efficiently. However, function of several OXPHOS complexes
that depend on the coordinated assembly of nuclear and mtDNA-encoded
proteins is impaired. Complex I activity in the Rattus
xenocybrid was 46% of the control mean; complex III was 37%, and
complex IV was 78%. These defects combined to restrict maximal
respiration to 12-31% of the control and M. spretus xenocybrids, as measured polarographically using isolated cybrid mitochondria. These defects are distinct to those previously reported for human/primate xenocybrids. It should be possible to produce other
mouse xenocybrid constructs with less severe OXPHOS phenotypes, to
model human mtDNA diseases.
 |
INTRODUCTION |
Mitochondrial DNA
(mtDNA)1 is a 16.5-kilobase
pair genome unique to mitochondria, which encodes 13 essential protein
subunits of the multimeric OXPHOS complexes I, III, IV, and V. Complex II is entirely nuclear gene-encoded. Unlike nuclear genes the mtDNA
exists in thousands of copies per cell, is replicated throughout life,
and in most animals including humans is maternally inherited. Transcription of mtDNA is linked to replication, and the 13 proteins are translated on mitochondrial ribosomes and assembled with around 60 nuclear gene products to produce the functional holocomplexes (for
recent reviews see Refs. 1 and 2).
The five OXPHOS complexes act as a redox pathway, transferring
electrons from NADH and FADH2 to molecular oxygen. The
passage of electrons is linked to proton efflux from the matrix through complexes I, III, and IV across the mitochondrial inner membrane. The
proton gradient in turn is the source of power for the
H+-ATP synthase (2). OXPHOS produces the majority of the
ATP of the cell and is also a major source of reactive oxygen species production. In efficiently respiring mitochondria around 2% of oxygen
consumed is directly converted into reactive oxygen species, and this
amount is increased when the respiratory chain is inhibited in in
vitro and in vivo studies (3).
Genetic defects of OXPHOS may therefore result from nuclear or mtDNA
gene mutations. Since the first descriptions of disease-related mtDNA
mutations appeared just over 10 years ago (4, 5), the catalogue of such
mutations has grown to over 50 (see Refs. 6 and 7 and MITOMAP).
Clincal presentations of mtDNA diseases are extremely variable,
although a few syndromes are associated with specific mtDNA defects.
Presentations range from severe and progressive neonatal or childhood
neuromuscular disease, to milder adult disease including muscle
weakness, cardiac disease, diabetes, vision, and hearing loss (see
Refs. 6-8).
Despite these genetic advances, our understanding of pathogenesis in
mitochondrial diseases remains poor, with little progress made on the
underlying causes of clinical heterogeneity and progression of
symptoms, which in turn has inhibited development of directed therapies. The creation of in vitro and in vivo
mouse models of mtDNA diseases is therefore of great current interest.
However the unique features of mitochondrial genetics including the
high cellular mtDNA copy number and the lack of demonstrated mechanisms of recombination have presented technical barriers to producing mtDNA
"knockout" mice.
Several groups have reported different approaches aimed at
directly manipulating the mitochondrial genotype of oocytes or zygotes
or using direct mitochondrial injection into oocytes (see Ref. 9). Two
other groups (10, 11) have reported production of transmitochondrial
mice using an embryonic stem (ES) cell approach and one of very few
characterized cultured mouse cell mtDNA mutants (a rRNA mutation
resulting in resistance to chloramphenicol). One of these groups
recently reported successful germ line transmission of this mtDNA
mutation, although from limited data presented to date the phenotype
appears to be post-natal lethal (12).
If the ES cell approach to producing transmitochondrial mice is
validated, the major limitation to producing models is now the lack of
available mtDNA mutants in cultured mouse cells. Another approach to
producing OXPHOS defects in mouse cells was suggested by Kenyon and
Moraes (13) who established that human mtDNA-less ( 0)
cells could be repopulated with closely related primate mtDNAs. The
resulting "xenomitochondrial cybrids" could replicate and transcribe the foreign mtDNAs and showed defective respiratory chain
complex I with preserved function of the other complexes (14).
Here we report the introduction of mtDNAs from different murid species
into mouse cells to produce mouse xenomitochondrial cybrids. We have
introduced closely related (Mus spretus) and more distantly
related (Rattus norvegicus) murid mtDNAs into a Mus
musculus 0 cell line, which in the latter case
results in multiple respiratory chain defects similar to some human
mtDNA diseases.
 |
EXPERIMENTAL PROCEDURES |
Cell Lines and Culture Conditions--
All cells were grown in
RPMI 1640 medium (Life Technologies, Inc.) supplemented with 10% fetal
bovine serum (Life Technologies, Inc.) at 37 °C and 5%
CO2. Primary fibroblast lines were created from a 2-day-old
laboratory mouse (M. musculus, CBA/C57Bl6 cross) and
5-week-old M. spretus (Spret/Ei, a gift from Dr. Simon
Foote, Walter & Eliza Hall Institute). Skin from the belly of
euthanized mice was washed with phosphate-buffered saline with 2×
penicillin/streptomycin (Life Technologies, Inc.) and incubated with
0.25% trypsin (Life Technologies, Inc.) in RPMI medium for 4 h at
4 °C, incubated at 37 °C for 20 min, then passed through a tissue
sieve using a glass pestle, and plated in complete medium in
75-cm2 tissue culture flasks (Nunc, Denmark). Media were
replaced twice weekly, and after 2-3 weeks the primary cultures began
to grow vigorously, and aliquots were viably frozen.
Two independent mouse 0 cell clones were used,
designated LMEB3 and LMEB5. These were produced from the parental line
LMTK by exposure to ethidium bromide and are described in
detail elsewhere (15). These mtDNA-less cells are auxotrophic for
uridine and pyruvate (see Ref. 16), and the medium was supplemented
with glucose to 4.5 mg/ml, uridine, 50 µg/ml, and pyruvate, 1 mM (RPMI/GUP medium).
The following cell lines were obtained from the ATCC: NRK52E (R.
norvegicus kidney epithelial cells), RN1T (R. norvegicus mammary tumor line), Chinese hamster ovary cells
(Cricetulus grigaeus), and Syrian hamster kidney cells
(Mesocricetus aureus).
Production of Transmitochondrial Cybrids--
Cybrids were
produced by enucleation of mitochondrial donor cells and fusion of the
cytoplasts with mouse 0 cells followed by selection for
respiratory-competent transformants as described in detail previously
for human cells (17). Cells used as mitochondrial donors included the
mouse primary fibroblast line, the M. spretus primary
fibroblast line, the Rattus lines NRK52E and RN1T, and the
hamster lines Chinese hamster ovary cells and Syrian hamster kidney.
Briefly, 5 × 106 cells were enucleated by
centrifugation at in an isopycnic Percoll (Amersham Pharmacia Biotech)
gradient in the presence of 10 µg/ml cytochalasin B (Sigma). The
cytoplast/karyoplast mixture was combined with 2 × 106 mouse 0 cells and then centrifuged at
20,000 × g for 10 min; the supernatant was aspirated
and the pellet overlaid with polyethylene glycol (Sigma) for 1 min. The
polyethylene glycol was then removed, and the cells were gently
resuspended in complete medium and plated at 104 and
105 cells per 100-mm dish in RPMI-GUP medium. After 24 h the medium was replaced with select medium as follows: RPMI
supplemented with 5% dialyzed fetal bovine serum (Life Technologies,
Inc.) and 50 µg/ml bromodeoxyuridine (Sigma). In this medium lacking uridine and pyruvate the 0 cells cannot grow, and the
bromodeoxyuridine kills surviving TK+ mitochondrial donor
cells so that only LMTK cybrids can survive. After 7-14
days cybrid clones were isolated using cloning cylinders, expanded, and
viably frozen. Three independent clones were frozen from each
successful fusion experiment, and cybrids were used in experiments from
passage 5 through passage 10.
To confirm the nuclear origin of the cybrids, karyotyping of a control
cybrid and a Rattus xenocybrid clone was performed. Cells
were grown in RPMI/GUP medium in a 25-cm2 flask. Cells were
treated with 50 ng/ml demecolcine (Sigma) for 5 h, harvested,
resuspended in 10 ml of 75 mM KCl, and incubated at room
temperature for 12 min. Cells were pelleted before being resuspended in
5 ml of fresh methanol/acetic acid (3:1). Cells were fixed overnight at
4 °C, pelleted, washed once in fixative, and then resuspended to
give a pale milky solution. Cells were then dropped onto wet,
acid-washed slides from a distance of 70 cm, allowed to dry, and
stained with Giemsa (Sigma).
mtDNA Genotyping by DNA Sequencing--
A mtDNA D-loop
fragment was generated by PCR from genomic DNA isolated from cybrid
clones. Primers were chosen to enable amplification from both mouse
(18) and R. norvegicus (19) mtDNA. The mouse amplicon was
461 base pairs in length, whereas the rat amplicon was 496 base pairs
due to intervening sequence insertions compared with the mouse mtDNA
(18, 19). The forward primer sequence was 5'-ctc aac ata gcc gtc aag
gc-3' representing nucleotides 15934-15953 (18), and the reverse
primer was 5'-acc aaa cct ttg tgt tta tgg g-3' representing nucleotides
59-80. PCR was performed using 1.0 unit of Taq polymerase
(Life Technologies, Inc.), 20 ng of DNA, and 35 cycles of 94 °C for
30 s, 55 °C for 1 min, and 72 °C for 1 min.
Sequencing was performed using 60 ng of purified amplicon, with a
Thermo Sequenase II dye terminator cycle sequencing kit (Amersham
Pharmacia Biotech). Sequencing reactions were visualized on an ABI 377 automated sequencer.
Southern Blot Determination of mtDNA--
The mouse and rat
D-loop PCR amplicons described above were used to probe mtDNA, whereas
a PCR fragment of mouse 18 S rRNA gene was used as a nuclear probe.
This PCR amplicon was 501 base pairs in length; the forward primer
sequence was 5'-ctg tgg taa ttc tag agc taa tac atg ccg-3',
representing positions 151-180 of the mouse 18 S rRNA gene
(GenBankTM accession number X00686) The reverse primer
sequence was 5'-tat acg cta ttg gag ctg gaa tta cc-3', representing
nucleotides 626-651. Probes were labeled with [32P]dCTP
using a RediPrime II random prime labeling kit (Amersham Pharmacia
Biotech). For each lane of a 0.85% agarose gel, 5 µg of genomic DNA
was loaded after restriction with SacI (Life Technologies, Inc.), which has a single restriction site in mouse and rat mtDNA. The
transfer, probe annealing, and washing was done using standard conditions.
Mitochondrial Protein Translation--
Mitochondrial translation
products were labeled with [35S]methionine as described
previously (20). Approximately 105 cells in single wells of
a 24-well tissue culture dish (Nunc) were washed with methionine-free
RPMI before adding 0.5 ml of the same medium containing 0.1 mg/ml
cycloheximide and incubating the cells at 37 °C, 5% CO2
for 15 min. After this preincubation 50 µCi of
[35S]methionine (ICN) was added to each well, and the
cells returned to the incubator for 2 h. Cold methionine (0.1 mM, Sigma) was then added, and the cells were incubated a
further 30 min. Cells were immediately harvested, centrifuged, and
frozen at 80 °C.
Cell pellets were prepared for electrophoresis by thawing and dilution
in 50 mM Tris, pH 6.8, containing 0.1% SDS and 1 mM -mercaptoethanol. The cell lysates were sonicated
with 3 pulses at setting 5 using a Tosco sonicator (MSE, Melbourne,
Australia). Electrophoresis of labeled proteins was performed using
15% acrylamide (1:36 bisacrylamide) mini-gels (CBS Scientific, Del
Mar, CA) with 10 µg of cellular protein per lane. Gels were
electrophoresed at 100 V for 30 min, fixed in methanol/acetic acid,
treated with "Amplify" (Amersham Pharmacia Biotech), and dried for autoradiography.
Lactate Measurement--
Lactate was measured in media using a
commercial kit (Sigma). Cybrids were grown to confluence in 24-well
culture dishes, and the media were replaced with 0.5 ml of fresh media
after two rinses with 1 ml of media, and the cells were incubated for
10 h. Samples of media were removed at 2-h intervals and tested
immediately for lactate concentration.
Mitochondrial Isolation and Polarographic
Analysis--
Mitochondrial isolation and polarography using freshly
isolated mitochondria was performed as described previously in detail for human cell mitochondria (17). Control and xenomitochondrial cybrids
(xenocybrids) were grown in paired cultures so that a control was
always processed alongside the experimental xenocybrid culture.
Cultures were expanded to around 109 cells by seeding
2 × 107 cells into roller bottles (Corning) in 200 ml
of complete medium, expanded after 4 or 5 days to 1000 ml, and then
harvested after another 4 days.
Mitochondria were isolated by digitonin lysis and homogenization,
followed by differential centrifugation (17). The mitochondria were
resuspended to around 20 mg/ml protein in isolation buffer and used
immediately for polarographic analysis. Protein was measured according
to the Lowry method. Aliquots were also frozen at 80 °C for
enzymological analysis.
Polarography was performed using an Instech (Plymouth Meeting, PA)
microelectrode and chamber coupled with a magnetic stirrer and an
Instech model 203 dual oxygen electrode amplifier with output to a
chart recorder. Each mitochondrial isolate was tested for respiratory
capacity using pyruvate plus malate, glutamate plus malate, and
succinate as substrates. Two runs were performed with each substrate,
and in each run two additions of ADP were made. Conditions and
experimental details were as described previously (17).
OXPHOS Enzymology--
Complex I (NADH:ubiquinone
oxidoreductase, EC 1.6.5.3), complex II (succinate:ubiquinone
oxidoreductase, EC 1.3.5.1), complex II + III (succinate:cytochrome
c oxidoreductase), and complex IV
(ferrocytochrome-c:oxygen oxidoreductase, or cytochrome oxidase, EC 1.9.3.1) activities were measured spectrophotometrically, essentially as described previously (17), with the following modifications. A single beam spectrophotometer was used for all assays
(Cintra 10, GBC Melbourne) instead of a dual-beam machine. For complex
I, the oxidation of NADH was followed at 340 nm (21) using ubiquinone-1
(Sigma) as electron acceptor. For the complex II, II + III, and IV
assays, conditions were as described previously (17) except the
single-beam machine was used. For each assay, each mitochondrial sample
was tested in triplicate.
 |
RESULTS |
Production of Transmitochondrial Cybrids--
Control cybrids
produced by fusion of the 0 cell clone LMEB3 with
enucleated M. musculus primary fibroblasts were obtained at
a frequency of around one per 5 × 103
0 cells used. Similar cybrid frequencies were obtained
in a fusion of LMEB3 with enucleated M. spretus cells
(diverged from M. musculus 2-3 million years ago, see Refs.
22-24, and see Fig. 1). Both the control
cybrids and M. spretus xenomitochondrial cybrids were similar in appearance and growth characteristics to each other and to
the parental LMTK cell line. Fusions using enucleated
Rattus NRK52E cells with LMEB5 and enucleated
Rattus RN1T cells with LMEB3 also produced cybrids at high
frequencies, around one per 104 0 cells
used. However both these sets of cybrid clones grew more slowly, showed
a morphology intermediate between the control cybrids and the
0 cells, and acidified the media much more quickly than
the control cybrids. The Mus/Rattus divergence is dated at
around 10 million years ago (Fig. 1). Table
I summarizes the amino acid
sequence differences between the M. musculus and R. norvegicus mtDNA-encoded proteins.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 1.
Brief phylogeny of the Muridae showing
divergence times estimated from molecular studies (22-24).
Divergence times are indicated by the scale below the
phenogram, in millions of years before present (m.y.b.p.).
Although M. spretus and R. norvegicus (subfamily
Murinae) mtDNA could readily be maintained in M. musculus
cells, Cricetulus and Mesocricetus (subfamily
Cricetinae) mtDNA could not.
|
|
Fusions of enucleated hamster cells with LMEB3 failed to produce any
cybrids in two experiments, one using Chinese hamster (C. grigaeus) cells and the other using Syrian golden hamster (M. aureus) cells. The Muridae subfamily Cricetinae, which
includes the hamsters, diverged from the Murinae subfamily around 16 million years ago (Fig. 1).
Karyotyping of a control (M. musculus) cybrid and a
Rattus xenocybrid revealed the same number of chromosomes,
with a mean of 40 ± 2.2 (n = 4 counts) for the
control, and 40 ± 1.5 (n = 6 counts) for the xenocybrid.
mtDNA Genotyping of Cybrids by DNA Sequencing--
For the
M. spretus and R. xenocybrids, mitochondrial
transfer was verified by direct sequencing of a PCR fragment of the
mtDNA D-loop region. The M. spretus xenocybrid showed 81%
identity with the published M. musculus sequence (18) for
the region sequenced (GenBankTM accession number AF287305).
The Rattus xenocybrids produced using NRK52E cells as
mitochondrial donors showed only 62% identity to M. musculus for the region sequenced and in agreement with the
published R. norvegicus sequence (19). The cybrids made from
RN1T cells showed a single nucleotide difference to the R. norvegicus sequence, an insertion of a C in a 8-C tract at
nucleotide pair 16075. This cell line is listed by ATCC as
Rattus rattus, but this almost perfect identity with the
R. norvegicus sequence indicates it is also derived from
R. norvegicus, as R. rattus would be expected to
show many more sequence differences in this highly polymorphic D-loop
region, based on molecular studies of these two species (25).
Southern Blot Determination of mtDNA in the Rattus
Xenocybrid--
Southern blot of control cybrid and Rattus
xenocybrid DNA after restriction with SacI and probing with
a mouse and rat mtDNA D-loop PCR amplicon showed similar mtDNA
hybridization signals. SacI has a single restriction site in
both mouse and rat mtDNA, resulting in a single band seen at 16.5 kilobase pairs. The blot showed that similar levels of mtDNA are
maintained in the xenocybrid compared with the control.
Mitochondrial Protein Translation in the Rattus
Xenocybrid--
Mitochondrial translation products labeled in the
presence of cycloheximide are shown after electrophoresis in Fig.
2. Most of the 13 proteins are
identifiable by mobility together with characteristic intensity of
labeling, as shown at left in Fig. 2. The profiles of the
control cybrid and Rattus xenocybrid are similar overall.
One mobility polymorphism between the M. musculus and
Rattus products is evident, possibly the ND2 gene
product NAD2, which was also seen in the parental NRK52E cells
(not shown). Two proteins appear to be produced in increased amounts,
possibly NAD4 and ATP6, while two others, likely NAD5 and cytochrome
b, appear to be decreased. The same pattern was observed in
two independent labeling experiments. The similarity of the profiles
shows that transcription and translation of the foreign mtDNA is not
markedly impaired.

View larger version (86K):
[in this window]
[in a new window]
|
Fig. 2.
Mitochondrial protein translation.
C, M. musculus control cybrid; X,
R. norvegicus xenocybrid. Mitochondrial translation products
are identified at left (ND, NADH dehydrogenase
subunits; CO, cytochrome oxidase subunits; ATP,
ATP synthase subunits; Cytb, apocytochrome b).
All mitochondrial proteins appear to be produced in the xenocybrid,
although ratios of some appear to differ in this long pulse (2 h)
labeling experiment, as indicated by the arrows. The
asterisk indicates a mitochondrial translation product
showing a mobility polymorphism, probably ND2. For each lane, 10 µg
of cellular protein was loaded, and the 15% polyacrylamide mini-gel
was electrophoresed under reducing conditions. CAP indicates
the labeling of control cybrid cells in the presence of chloramphenicol
in addition to cycloheximide.
|
|
Lactate Measurement--
Fig. 3
shows the lactate production from the control and M. spretus
cybrids, the Rattus cybrid, and the 0 cell
line. A respiratory defect is signaled in the Rattus
xenocybrid by the 10-fold greater lactate production compared with the
control cybrid, whereas the M. spretus xenocybrid shows
similar low lactate production to the control (Fig. 3). The
0 cell line produced 2-fold greater amounts of lactate
than the Rattus xenocybrid, indicating that the cybrid was
able to produce some ATP oxidatively.

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 3.
Lactate production in xenocybrids and
0 cells. A severe OXPHOS defect is
signaled in the Rattus xenocybrid ( ) by a 10-fold
increased lactate production compared with the control and M. spretus cybrids ( ). The LMEB3 0 cell line ( ),
without oxidative ATP production, shows a further 2-fold increase,
showing that the Rattus xenocybrid is producing some ATP
aerobically.
|
|
Polarographic Measurement of OXPHOS in Xenocybrids--
Fig.
4 shows typical polarograph traces of
site I (glutamate + malate) and site II (succinate) oxidation in the
control and Rattus xenocybrid mitochondria. The control
traces (A and B) show good coupling to ADP
stimulation and high respiration rates and ADP/O ratios. In the
Rattus xenocybrid (C and D), site
I-linked respiration is impaired but remains coupled to ADP
availability, whereas site II-linked respiration shows a more severe
defect, with little stimulation by added ADP. Comparison of the mean
specific respiratory rates from three independent experiments (Table
II) revealed that the M. spretus cybrid showed similar respiratory capacity to the control,
whereas the Rattus cybrid state III (ADP-stimulated) rates
were significantly lower than the control. This was true for site I
substrates (31% mean control rates) and succinate (12% mean control
rate). The ADP/O ratios obtained with site I substrates were also
significantly lower in the Rattus cybrid (71% controls, Table II). These results are consistent with defects in either or both
complex III or IV limiting respiratory chain electron flow, possibly
combined with a complex I defect.

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 4.
Polarographic analysis of OXPHOS using
freshly isolated cybrid mitochondria. The control cybrid
mitochondria (traces A and B) show a normal well
coupled profile of ADP-stimulated OXPHOS. The Rattus
xenocybrid (traces C and D) shows a greatly
reduced rate of oxygen consumption with glutamate + malate, even lower
with succinate, and a lowered ADP/O ratio with glutamate + malate. The
ADP/O ratio was not measurable with succinate in the Rattus
xenocybrid due to the state III rate deteriorating before all the added
ADP was phosphorylated. The numbers to the left
of each trace show the state III (ADP-stimulated) respiration rates as
ng of atom O reduced per min per mg of mitochondrial protein, and the
numbers to the right of the traces show ADP/O
ratios. Substrates used were: g+m, glutamate + malate;
succ., succinate.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Polarographic analysis of OXPHOS in mitochondria isolated from
xenocybrids
Numbers are mean ± S.D. of three mitochondrial isolates studied.
RCR (respiratory control ratio) is the ratio of state III to subsequent
state IV respiration. ADP/O ratio indicates the number of ADP molecules
phosphorylated per oxygen atom used.
|
|
OXPHOS Enzymology--
Table III
summarizes the mean activity of OXPHOS complexes I, II, II + III, and
IV measured in triplicate using three independent mitochondrial
isolates from each of the control, M. spretus and Rattus xenocybrids. No significant differences were found
for the M. spretus xenocybrid compared with the control. The
Rattus xenocybrid showed normal complex II activity with
varying defects of the other complexes. Complex I (rotenone-sensitive
activity) was significantly decreased to 46% of the control levels,
whereas complex IV showed a partial but significant defect with 78%
control activity (Table III). The most striking defect was indicated by the II + III assay result, showing only 37% of the control activity (Table III). Together with the preserved complex II activity, this result suggests a severe complex III defect since this linked assay is
normally rate-limited by complex II (26).
View this table:
[in this window]
[in a new window]
|
Table III
Activities of OXPHOS enzyme complexes in mitochondria from xenocybrids
Numbers are mean ± S.D., N = 3 mitochondrial
isolates.
|
|
 |
DISCUSSION |
By introducing R. norvegicus mtDNA into a mouse
mtDNA-less cell line, we have produced a new mouse in vitro
model of a severe mtDNA OXPHOS defect. Only a handful of mtDNA mouse
cell mutants have been described, the best characterized being a point
mutation in the 16 S rRNA gene resulting in resistance of the
mitochondrial ribosome to chloramphenicol (CAPR) (27) which
results in multiple respiratory chain defects (10, 28).
The lack of methods to produce targeted mtDNA knockouts has limited
attempts to produce mtDNA mutant mice. A transfection approach using a
DNA construct linked to a mitochondrial target peptide leader sequence
is promising but has not yet succeeded in transforming mitochondria in
cultured cells (29, 30). Kenyon and Moraes (13) pioneered the approach
of xenomitochondrial cybrids by showing that only the most closely
related primate mtDNAs could be maintained in human 0
cells. These human/primate xenomitochondrial cybrids exhibited defects
in respiratory chain complex I (14) and an increased sensitivity to
programmed cell death when treated with complex I inhibitors (31).
The finding by Moraes et al. (32) that human cells
preferentially replicate even defective human mtDNA over introduced
normal primate mtDNAs showed that mtDNA determinants for
trans-acting factors may be more important than OXPHOS functionality.
In the present studies we found that there is also a limit on mtDNA
compatibility as indicated by the inability of the mouse 0 cells to maintain hamster mtDNA. Divergence of
hamsters (Muridae subfamily Cicetidae) from the Murinae subfamily
including mice and rats was around 16 million years ago (Fig. 1 (22)).
The Mus/Rattus divergence was around 10 million years ago
(Fig. 1 (23)) and may approximate the limit of compatibility in this system. The resulting xenocybrids exhibited a severe OXPHOS impairment (Table II and III and Figs. 3 and 4) despite showing preserved mtDNA
replication and translation (Fig. 3). This shows the defects are
consequent to the mismatches between the mouse nuclear OXPHOS subunits
and the Rattus mtDNA subunits (Table I; see also
accompanying article (33)). A marked defect of complex I was seen in
the Rattus xenocybrids (Table III) but unlike the
human/primate xenocybrids there was also a striking defect of complex
III together with a partial defect of complex IV (Table III). This
shows that predictions from the human/primate system do not translate
directly into the murid system.
The number of amino acid substitutions range from only 3 in the highly
conserved COX-2 protein, to 133 in NAD5 (Table I), making it
difficult to predict which changes are functionally important. The
suggestion of a severe complex III defect is particularly interesting
since cytochrome b is the only mtDNA-encoded subunit of this
complex. Cytochrome b shows 26 amino acid differences between M. musculus and R. norvegicus (Table I).
The polarographic results (Table II and Fig. 4) show that
succinate-linked respiration is more severely impaired than site
1-linked respiration, despite the latter requiring the same electron
transfer pathway through complexes III and IV. This could result from
substrate inhibition exacerbating the complex III defect, as there will
be a greater steady state ubiquinol concentration during
succinate oxidation compared with site 1-linked substrate oxidation due
to the higher specific activity of complex II over complex I.
M. spretus and M. musculus diverged approximately
2-3 million years ago (Fig. 1). Although the present studies show no
differences in OXPHOS capacity for the M. spretus
xenocybrids, further studies may show subtle but important defects in
this model. The levels of M. spretus mtDNA were too
low in the mice produced by Irwin et al. (9) to conclude
there were no pathogenic effects, and creation of this mouse would be
an important proof of the principle from which to proceed to make other
xenomitochondrial mice using the ES cell approach.
By making further xenomitochondrial constructs with species
intermediate between M. spretus and Rattus, it
should be possible to produce cybrids with intermediate OXPHOS
phenotypes. By comparative studies of OXPHOS and mtDNA sequences from
the species used, it should be possible to gain important new insights
into the nuclear-mtDNA-encoded subunit interactions, in addition to the
potential value of this system in producing mouse models of human mtDNA
diseases. Evolution has provided a rich source of options. The Muridae
is the most successful family of the order Rodentia, having the
greatest number of extant species of any mammalian family (22, 24).
There are literally dozens of potential constructs that can be
produced. The Gerbillinae subfamily of Muridae, the gerbils, are
intermediate in divergence to Rattus and the hamsters (Fig. 1) and may
produce viable xenocybrids. We would predict these constructs to
produce severe OXPHOS defects if the mtDNAs could be replicated.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Simon Foote for the M. spretus specimen. We also thank Professor Richard Cotton,
Professor Ed Byrne, and Dr. Andrew Wilks for support.
 |
FOOTNOTES |
*
This work was supported by National Health and Medical
Research Council of Australia Grant 970543 (to I. T), grants-in-aid from the Ramaciotti Foundation, ANZ trustees, and the Percy Baxter trust.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of a University of Melbourne postgraduate scholarship.
§
To whom correspondence should be addressed. Tel.: 61-3-9288-2977;
Fax: 61-3-9288-2989; E-mail: trouncia@svhm.org.au.
Published, JBC Papers in Press, July 24, 2000, DOI 10.1074/jbc.M004070200
 |
ABBREVIATIONS |
The abbreviations used are:
mtDNA, mitochondrial
DNA;
OXPHOS, oxidative phosphorylation;
ES cells, embryonic stem cells;
PCR, polymerase chain reaction.
 |
REFERENCES |
| 1.
|
Clayton, D. A.
(2000)
Exp. Cell Res.
255,
4-9
|
| 2.
|
Saraste, M.
(1999)
Science
283,
1488-1492
|
| 3.
|
Kwong, L. K.,
and Sohal, R. S.
(1998)
Arch. Biochem. Biophys.
350,
118-126
|
| 4.
|
Wallace, D. C.,
Singh, G.,
Lott, M. T.,
Hodge, J. A.,
Schurr, T. G.,
Lezza, A. M. S.,
Elsas, L. J., II,
and Nikoskelainen, E. K.
(1988)
Science
242,
1427-1430
|
| 5.
|
Holt, I. J.,
Harding, A. E.,
and Morgan-Hughes, J. A.
(1988)
Nature
331,
717-719
|
| 6.
|
Wallace, D. C.
(1999)
Science
283,
1482-1487
|
| 7.
|
Graff, C.,
Clayton, D. A.,
and Larsson, N-G.
(1999)
J. Int. Med.
246,
11-23
|
| 8.
|
Lightowlers, R. N.,
Chinnery, P. F.,
Turnbull, D. M.,
and Howell, N.
(1997)
Trends Genet.
13,
450-455
|
| 9.
|
Irwin, M. H.,
Johnson, L. W.,
and Pinkert, C. A.
(1999)
Transgenic Res.
8,
119-123
|
| 10.
|
Levy, S. E.,
Waymire, K. G.,
Kim, Y. L.,
MacGregor, G. R.,
and Wallace, D. C.
(1999)
Transgenic Res.
8,
137-145
|
| 11.
|
Marchington, D. R.,
Barlow, D.,
and Poulton, J.
(1999)
Nat. Med.
5,
957-960
|
| 12.
|
Wallace, D. C.,
Levy, S. E.,
and Sligh, J. E.
(1999)
Am. J. Hum. Genet.
65,
18 (abstr.)
|
| 13.
|
Kenyon, L.,
and Moraes, C. T.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
9131-9135
|
| 14.
|
Barrientos, A.,
Kenyon, L.,
and Moraes, C. T.
(1998)
J. Biol. Chem.
273,
14210-14217
|
| 15.
|
Trounce, I. A.,
Schmiedel, J.,
Hsiu-Chuan, Y.,
Hossini, S.,
Brown, M. D.,
Olsen, G.,
and Wallace, D. C.
(2000)
Nucleic Acids Res.
28,
2164-2170
|
| 16.
|
King, M. P.,
and Attardi, G.
(1996)
Methods Enzymol.
264,
313-334
|
| 17.
|
Trounce, I. A.,
Kim, Y. L.,
Jun, A. S.,
and Wallace, D. C.
(1996)
Methods Enzymol.
264,
484-509
|
| 18.
|
Bibb, M. J.,
Van Etten, R. A.,
Wright, C. T.,
Walberg, M. W.,
and Clayton, D. A.
(1981)
Cell
26,
167-180
|
| 19.
|
Gadaleta, G.,
Pepe, G.,
De Candia, G.,
Quagliariello, C.,
Sbisa, E.,
and Saccone, C.
(1989)
J. Mol. Evol.
28,
497-516
|
| 20.
|
Brown, M. D.,
Yang, C.-C.,
Trounce, I.,
Torroni, A.,
Lott, M. T.,
and Wallace, D. C.
(1992)
Am. J. Hum. Genet.
51,
378-385
|
| 21.
|
Estornell, E.,
Fato, R.,
Pallotti, F.,
and Lenaz, P.
(1993)
FEBS Lett.
332,
127-131
|
| 22.
|
Catzeflis, F. M.,
Dickerman, A. W.,
Michaux, J.,
and Kirsch, J. A. W.
(1993)
in
Mammal Phylogeny: Placentals
(Szalay, F. S.
, Novacek, M. J.
, and McKenna, M. C., eds)
, pp. 159-172, Springer-Verlag Inc., New York
|
| 23.
|
Bonhomme, F.,
and Guenet, J.-L.
(1996)
in
Genetic Variants and Strains of the Laboratory Mouse
(Lyon, M. F.
, Rastan, S.
, and Brown, S. D. M., eds)
, pp. 1577-1595, Oxford University Press, Oxford
|
| 24.
|
Silver, L. M.
(1995)
Mouse Genetics
, Oxford University Press, New York
|
| 25.
|
Verneau, O.,
Caatzeflis, F.,
and Furano, A. V.
(1997)
J. Mol. Evol.
45,
424-436
|
| 26.
|
Taylor, R. W.,
Birch-Machin, M. A.,
Bartlett, K.,
and Turnbull, D. M.
(1993)
Biochim. Biophys. Acta
1181,
261-265
|
| 27.
|
Blanc, H.,
Wright, C. T.,
Bibb, M. J.,
Wallace, D. C.,
and Clayton, D. A.
(1981)
Proc. Natl. Acad. Sci. U. S. A.
78,
3789-3793
|
| 28.
|
Howell, N.,
and Nalty, M. S.
(1988)
Somatic Cell Mol. Genet.
14,
185-193
|
| 29.
|
Seibel, P.,
Trappe, J.,
Villani, G.,
Klopstock, T.,
Papa, S.,
and Reichmann, H.
(1995)
Nucleic Acids Res.
23,
10-17
|
| 30.
|
Seibel, M.,
Bachmann, C.,
Schmiedel, J.,
Wilken, N.,
Wilde, F.,
Reichmann, H.,
Isaya, G.,
and Seibel, P.
(1999)
Biol. Chem.
380,
961-967
|
| 31.
|
Barrientos, A.,
and Moraes, C. T.
(1999)
J. Biol. Chem.
274,
16188-16197
|
| 32.
|
Moraes, C. T.,
Kenyon, L.,
and Hao, H.
(1999)
Mol. Biol. Cell
10,
3345-3356
|
| 33.
|
Dey, R.,
Barrientos, A.,
and Moraes, C. T.
(2000)
J. Biol. Chem.
275,
31520-31527
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Burzynski, M. Zbawicka, D. O. F. Skibinski, and R. Wenne
Doubly Uniparental Inheritance Is Associated With High Polymorphism for Rearranged and Recombinant Control Region Haplotypes in Baltic Mytilus trossulus
Genetics,
November 1, 2006;
174(3):
1081 - 1094.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.C. Spikings, J. Alderson, and J.C.St. John
Transmission of mitochondrial DNA following assisted reproduction and nuclear transfer
Hum. Reprod. Update,
July 1, 2006;
12(4):
401 - 415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kasahara, K. Ishikawa, M. Yamaoka, M. Ito, N. Watanabe, M. Akimoto, A. Sato, K. Nakada, H. Endo, Y. Suda, et al.
Generation of trans-mitochondrial mice carrying homoplasmic mtDNAs with a missense mutation in a structural gene using ES cells
Hum. Mol. Genet.,
March 15, 2006;
15(6):
871 - 881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H El Shourbagy, E. C Spikings, M. Freitas, and J. C St John
Mitochondria directly influence fertilisation outcome in the pig
Reproduction,
February 1, 2006;
131(2):
233 - 245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Bayona-Bafaluy, S. Muller, and C. T. Moraes
Fast Adaptive Coevolution of Nuclear and Mitochondrial Subunits of ATP Synthetase in Orangutan
Mol. Biol. Evol.,
March 1, 2005;
22(3):
716 - 724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C St John, R. E I Lloyd, E. J Bowles, E. C Thomas, and S. El Shourbagy
The consequences of nuclear transfer for mammalian foetal development and offspring survival. A mitochondrial DNA perspective
Reproduction,
June 1, 2004;
127(6):
631 - 641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. St. John and G. Schatten
Paternal Mitochondrial DNA Transmission During Nonhuman Primate Nuclear Transfer
Genetics,
June 1, 2004;
167(2):
897 - 905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. McKenzie, I. A. Trounce, C. A. Cassar, and C. A. Pinkert
Production of homoplasmic xenomitochondrial mice
PNAS,
February 10, 2004;
101(6):
1685 - 1690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. McKenzie, M. Chiotis, C. A. Pinkert, and I. A. Trounce
Functional Respiratory Chain Analyses in Murid Xenomitochondrial Cybrids Expose Coevolutionary Constraints of Cytochrome b and Nuclear Subunits of Complex III
Mol. Biol. Evol.,
July 1, 2003;
20(7):
1117 - 1124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Battersby and E. A. Shoubridge
Selection of a mtDNA sequence variant in hepatocytes of heteroplasmic mice is not due to differences in respiratory chain function or efficiency of replication
Hum. Mol. Genet.,
October 1, 2001;
10(22):
2469 - 2479.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|